Lok Sabha Question No. 645 (UNSTARRED), answered on 2022-12-09
Subject: WHO GCTM
Ministry: AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)
Asked by: Anumula Revanth Reddy

## GOVERNMENT OF INDIA MINISTRY OF AYUSH

## LOK SABHA UNSTARRED QUESTION NO-645 TO BE ANSWERED ON 09/12/2022

## WHO GCTM

## 645. SHRI ANUMULA REVANTH REDDY:

Will the MINISTER OF AYUSH be pleased to state:

(a)  whether the Government has endorsed the association of the WHO Global Centre for  Traditional  Medicine  (WHO  GCTM)  in  Jamnagar,  Gujarat  and  if  so  the  details thereof;

(b) the reasons behind the selection of Gujarat State to felicitate the project;

(c) the  number  of  global  wellness,  bolster  evidence-based  research,  training,  and awareness Programme for Traditional Medicine conducted in the last two years, Statewise and year-wise; and

(d) the funds allocated and utilized under the Global Centre for Traditional Medicine?

## ANSWER

## THE MINISTER OF AYUSH (SHRI SARBANANDA SONOWAL)

(a)  Yes, the Government of India endorsed the association of the WHO Global Centre for  Traditional  Medicine  (WHO  GCTM)  in  Jamnagar,  Gujarat.  The  Ministry  of Ayush,  Government  of  India  signed  a  Host  Country  Agreement  with  WHO  on 25.03.2022 for the same.

(b)    The  decision  for  the  selection  of  Gujarat  state  for  felicitating  the  project,  was jointly taken by the Ministry of Ayush and World Health Organization (WHO).

(c)  The Ministry of Ayush has undertaken various evidence-based research, trainings, and awareness Programmes for global wellness through Traditional Medicine. Details for the same are as follows:

-  Signed  40  Institute  Level  MoUs  with  foreign  Institutes  for  undertaking Collaborative Research/ Academic collaboration etc.
-  Clinical  trial  of  Ashwagandha  for  promoting  recovery  from  Covid-19  in  the UK in collaboration with the London School of Hygiene & Tropical Medicine (LSHTM), UK.
-  Understanding the Molecular Mechanism of Guduchyadi Tablet in Combating Covid-19 Infection in-Vitro & in-Vivo Study in collaboration with Frankfurter lnnovationszentrum Biotechnologie (FIZ) GmbH, Germany.
-  AYUSH PHFI research study entitled 'Assessment of integration of AYUSH into the public health system for combating COVID-19' in collaboration with WHO.
-  Evidence-based  research  for  traditional  medicine  being  undertaken  at  CSIRInstitute  of  Himalayan  Bioresource  Technology  (IHBT),  Palampur  are  as follows:
- o Validation of immuno boosting properties of Carum carvi and Bunium persicum based on traditional knowledge is being done.
- o An  ayurvedic  medicine,  Phalatrikadi  kwath  was  found  efficacious against NAFLD in rat models.
- o The scientific validation of Ayurveda formulations Arjuna ksheerapaka and Trikatu were also performed.
-  Training Programs
- o CSIR - National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram, imparted training to MSME industries in Ayurveda on 24 th January  2020  on  Quality  Assurance  in  collaboration with Ayurveda Manufacturers Association Research Foundation Kerala and Kerala Ayurveda Cooperative Society, Calicut
- o One  awareness  cum  training  program  "Continuing  Medical  Education (CME) programme for Teachers and Doctors" of the AYUSH discipline was  Organized  in  association  with  Rashtriya  Ayurveda  Vidyapeeth (National Academy of Ayurveda) at CSIR-Indian Institute of Chemical Technology(IICT), Hyderabad between 25th-30th May 2022.

.

-  organized  a  three-day  mega  event  'Global  Ayush  Investment  and  Innovation Summit' from 20 to 22 April 2022 at Gandhinagar, Gujarat which provided a platform  for  the  global  investors  from  different  countries  working  in  the different fields of Health care sector.

(d)  The financial implications of Rs. 130.00 Cr (approx.) have been approved by the Ministry of Ayush towards the functional cost of the Interim Office of WHOGCTM and Funds of Rs. 63.26 Cr have been released till date.

********